Downstream Polish And Viral Clearance

  1. Optimized Purity Of A Monoclonal Antibody, Carsten Voß Video 4/12/2016

    Purity, recovery, and elution volume are important factors and parameters when screening multiple media (resins) for the development of efficient, robust, and economical production processes.

  2. What Is Mixed-Mode Chromatography? 4/12/2016

    There are a variety of advantages of mixed-mode interactions have been observed beyond simply finer discrimination between product and impurities.

  3. Pellicon® Capsule: How Is It Made And How Does It Work? 6/17/2022

    See what makes the Pellicon® Capsule a true single-use TFF device that comes ready to process mAbs and ADCs in minutes.

  4. Targeting The Fast Lane With Optimized Viral Detection 4/6/2023

    Discover a groundbreaking method that allows you to accelerate viral detection by combining the broad range of NGS with the sensitivity of PCR.

  5. Strategies For Viral Inactivation And Filtration In Multispecifics 6/2/2025

    In this segment from the Bioprocess Online Live event, “Challenges And Considerations For Purifying Multispecific Molecules,” our panelists cover molecule sensitivity to low pH and the use of detergent-based viral inactivation, as well as evaluating the suitability of platform viral filters.

  6. Redefine Your Oligonucleotide Manufacturing 4/22/2025

    Streamline oligo production and scale confidently. Explore high-performing, purpose-built automated equipment designed to ensure safety, efficiency, and purity, from synthesis through concentration.

  7. Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters 11/11/2025

    Explore how a new, climate-neutral manufacturing facility strengthens biopharma supply chains. Understand the benefits of its advanced filtration technologies and commitment to environmental sustainability.

  8. The Blazar® Platform In A Minute 3/12/2021

    The Blazar® Rodent Panel from the BioReliance® portfolio can speed cell line characterization and bulk harvest lot release testing. This degenerate PCR-based method accelerates characterization by reducing timelines by up to 80% and replaces the use of animals.

  9. Maintaining Downstream Quality In Multi-Specific Antibody Manufacturing 8/9/2023

    Bayer Sr. Director, Bioprocess Technologies, Amir Goudarzi, Ph.D., addresses audience questions on downstream multi-specific mAb processing challenges, specifically purification in terms of CPP and QRA, and microbial or thermal degradation, in this segment of the Bioprocess Online Live event, Process Development For A Diverse mAb Pipeline.

  10. Purification Strategies For New Classes Of Antibodies 8/9/2023

    In this segment of the Bioprocess Online Live event, Process Development For A Diverse mAb Pipeline, Bayer’s Sr. Director, Bioprocess Technologies, Amir Goudarzi, Ph.D., addresses an audience question concerning purification strategies in the growing multi-specific antibody field.